Three Months

Nine Months

For the Periods Ended March 31

2025

2024

2025

2024

Net sales

Animal Health

$

258,377

$

181,333

$

670,318

$

514,967

Mineral Nutrition

66,774

64,228

189,086

181,601

Performance Products

22,674

17,662

58,114

47,947

Total segments

$

347,825

$

263,223

$

917,518

$

744,515

Depreciation and amortization

Animal Health

$

11,369

$

7,695

$

29,318

$

22,392

Mineral Nutrition

524

601

1,555

1,907

Performance Products

277

432

902

1,291

Total segments

$

12,170

$

8,728

$

31,775

$

25,590

Adjusted EBITDA

Animal Health

$

63,123

$

36,524

$

161,684

$

104,317

Mineral Nutrition

5,762

4,665

15,226

11,053

Performance Products

3,336

2,371

7,513

4,597

Total segments

$

72,221

$

43,560

$

184,423

$

119,967

Reconciliation of income before income taxes to Adjusted EBITDA

Income before income taxes

$

29,688

$

12,922

$

44,146

$

4,508

Interest expense, net

9,355

4,575

25,992

13,798

Depreciation and amortization – Total segments

12,170

8,728

31,775

25,590

Depreciation and amortization – Corporate

446

468

1,419

1,387

Corporate costs

17,335

13,856

50,706

42,160

Acquisition-related cost of goods sold

1,708

211

3,342

521

Acquisition-related other

636

512

12,875

512

Pension settlement cost

—

10,674

Brazil employment taxes

—

4,202

Insurance settlement gain

(1,546)

(274)

(2,803)

(274)

Stock-based compensation expense

179

135

538

296

Phibro Forward income growth initiatives - cost of goods sold ⁽¹⁾

3,798

—

3,798

—

Phibro Forward income growth initiatives - SG&A ⁽¹⁾

3,980

—

6,026

Foreign currency (gains) losses, net

(5,528)

2,427

6,609

16,593

Adjusted EBITDA – Total segments

$

72,221

$

43,560

$

184,423

$

119,967